Insulin and myocardial blood flow

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Metabolic Syndrome

Background:

• Insulin's role in myocardial substrate metabolism is well-established, but its cardiovascular effects, particularly vasodilation, are increasingly recognized.
• Glucose-insulin-potassium (GIK) infusion is experiencing a resurgence for acute myocardial infarction treatment, prompting renewed interest in insulin's cardiac mechanisms.

Purpose of the Study:

• To review the physiological and pathophysiological roles of insulin in cardiac vasculature.
• To elucidate the clinical significance of insulin's vascular effects during myocardial ischemia and coronary artery disease development.

Main Methods:

• Review of existing literature on insulin's effects on coronary arteries and myocardial blood flow.
• Analysis of studies investigating insulin's vasodilatory mechanisms and clinical implications in various cardiovascular conditions.

Main Results:

• Insulin acts as a vasodilatory hormone in coronary arteries, enhancing myocardial blood flow and decreasing vascular resistance in a dose-dependent manner.
• Insulin's vasodilatory effects can improve myocardial blood flow even in conditions like obesity, type 1 diabetes, and coronary artery disease, though these effects may be blunted.
• While acute insulin administration may be beneficial, chronic hyperinsulinemia is identified as an independent risk factor for coronary artery disease.

Conclusions:

• Insulin's vasodilatory actions in coronary arteries may contribute to the beneficial effects of GIK therapy during acute myocardial infarction.
• Understanding insulin's dual role—acute vasodilation versus chronic risk factor—is crucial for managing cardiovascular health, particularly in patients with metabolic dysfunction and coronary artery disease.